Literature DB >> 31828460

Double Threat: Interplay of Celiac Disease with Inflammatory Bowel Disease.

John Gubatan1, George Triadafilopoulos2, Nielsen Q Fernandez-Becker2.   

Abstract

Entities:  

Year:  2020        PMID： 31828460     DOI： 10.1007/s10620-019-05994-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

1.  Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.

Authors:  Jürgen Glas; Johannes Stallhofer; Stephan Ripke; Martin Wetzke; Simone Pfennig; Wolfram Klein; Jörg T Epplen; Thomas Griga; Uwe Schiemann; Martin Lacher; Sibylle Koletzko; Matthias Folwaczny; Peter Lohse; Burkhard Göke; Thomas Ochsenkühn; Bertram Müller-Myhsok; Stephan Brand
Journal:  Am J Gastroenterol       Date:  2009-05-19       Impact factor: 10.864

Review 2.  The IBD interactome: an integrated view of aetiology, pathogenesis and therapy.

Authors:  Heitor S P de Souza; Claudio Fiocchi; Dimitrios Iliopoulos
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-23       Impact factor: 46.802

Review 3.  Inflammatory bowel disease and celiac disease: overlaps and differences.

Authors:  Virginia Pascual; Romina Dieli-Crimi; Natalia López-Palacios; Andrés Bodas; Luz María Medrano; Concepción Núñez
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 4.  Vitamin D in inflammatory bowel disease: more than just a supplement.

Authors:  John Gubatan; Alan C Moss
Journal:  Curr Opin Gastroenterol       Date:  2018-07       Impact factor: 3.287

5.  Link Between Celiac Disease and Inflammatory Bowel Disease.

Authors:  Ayesha Shah; Marjorie Walker; Daniel Burger; Neal Martin; Moritz von Wulffen; Natasha Koloski; Mike Jones; Nicholas J Talley; Gerald J Holtmann
Journal:  J Clin Gastroenterol       Date:  2019-08       Impact factor: 3.062

6.  Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease.

Authors:  D Fina; M Sarra; R Caruso; G Del Vecchio Blanco; F Pallone; T T MacDonald; G Monteleone
Journal:  Gut       Date:  2007-10-26       Impact factor: 23.059

7.  Low Serum Vitamin D During Remission Increases Risk of Clinical Relapse in Patients With Ulcerative Colitis.

Authors:  John Gubatan; Shuji Mitsuhashi; Talia Zenlea; Laura Rosenberg; Simon Robson; Alan C Moss
Journal:  Clin Gastroenterol Hepatol       Date:  2016-06-04       Impact factor: 11.382

8.  HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease.

Authors:  Kati Karell; Andrew S Louka; Simon J Moodie; Henry Ascher; Fabienne Clot; Luigi Greco; Paul J Ciclitira; Ludvig M Sollid; Jukka Partanen
Journal:  Hum Immunol       Date:  2003-04       Impact factor: 2.850

9.  HLA-DQ and risk gradient for celiac disease.

Authors:  Francesca Megiorni; Barbara Mora; Margherita Bonamico; Maria Barbato; Raffaella Nenna; Giulia Maiella; Patrizia Lulli; Maria Cristina Mazzilli
Journal:  Hum Immunol       Date:  2008-11-21       Impact factor: 2.850

10.  Phenotype and Clinical Course of Inflammatory Bowel Disease With Co-existent Celiac Disease.

Authors:  Chung Sang Tse; Parakkal Deepak; Jaime De La Fuente; Adam C Bledsoe; Joseph J Larson; Joseph A Murray; Konstantinos A Papadakis
Journal:  J Crohns Colitis       Date:  2018-07-30       Impact factor: 9.071
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.